FDA Inspection 1161444 — Effingham Equity
The FDA completed an inspection of Effingham Equity on January 31, 2022 in Effingham, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- January 31, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Effingham, IL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1575 | 21 CFR 225.42(b)(4) | Integrity and identity |
| 21300 | 21 CFR 507.33(a) | Hazard Analysis |
| 21301 | 21 CFR 507.34(a)(1) | Preventive Controls |
| 21303 | 21 CFR 507.34(c)(1) | Process Controls |